OGI.V - OrganiGram Holdings Inc.

TSXV - TSXV Delayed Price. Currency in CAD
7.00
-0.65 (-8.50%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close7.65
Open7.75
Bid7.00 x 0
Ask7.05 x 0
Day's Range6.61 - 7.82
52 Week Range2.58 - 8.07
Volume4,339,907
Avg. Volume1,313,365
Market Cap879.326M
Beta4.95
PE Ratio (TTM)2,333.33
EPS (TTM)0.00
Earnings DateJul 27, 2017 - Jul 28, 2017
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est7.47
  • CNW Group6 days ago

    Organigram signs supply agreement with Newfoundland and Labrador Liquor Corporation

    MONCTON, NB, Sept. 14, 2018 CNW/ - Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQX:OGRMF - News), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of medical marijuana, is pleased to announce that the Company has signed a supply agreement with the Newfoundland and Labrador Liquor Corporation (NLC) in anticipation of the launch of a legal, adult use recreational cannabis market in the province. "We are pleased to have been accepted as a supplier to NLC," says Greg Engel, Organigram's Chief Executive Officer.

  • CNW Group6 days ago

    Organigram Update on Proposed Investment in European CBD Hemp Producer Eviana

    MONCTON, NB, Sept. 14, 2018 /CNW/ - Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQX:OGRMF - News), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of medical marijuana, is pleased to update the market on its proposed investment in Eviana Health Corporation ("Eviana"). The information provided in this news release is meant to update and replace the information previously disseminated by Organigram on June 4, 2018 regarding a proposed investment in Eviana.

  • Global Cannabis Partnership Welcomes New Members
    CNW Group7 days ago

    Global Cannabis Partnership Welcomes New Members

    SAINT JOHN, NB, Sept. 13, 2018 /CNW/ - Momentum continues to build for the establishment of a Responsible Cannabis Framework as eight more organizations join the Global Cannabis Partnership (GCP), in its newly opened Member category. "We expect membership to expand as more and more stakeholders recognize the necessity of social responsibility policies and programs and want to be at the table to collaborate," says Kim Wilson, Executive Director of the GCP.

  • Baystreet7 days ago

    Stocks in play: Organigram Holdings Inc.

    Announced the closing of its strategic investment in convertible secured debentures, to be purchased ...

  • CNW Group7 days ago

    Organigram invests in Hyasynth Biologicals Inc., helps bring transformative "cellular agriculture" to Canadian cannabis industry

    MONCTON, NB, Sept. 13, 2018 /CNW/ - Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQX:OGRMF - News), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of medical marijuana, is pleased to announce the closing of its strategic investment in convertible secured debentures (the "Debentures"), to be purchased in three tranches and valued in the aggregate at $10 million, of Hyasynth Biologicals Inc. ("Hyasynth"), a biotechnology company based in Montreal and leader in the field of cannabinoid science and biosynthesis.

  • CNW Group8 days ago

    Organigram Chosen to Include Award-Winning Sativa Flower, Wabanaki, in World's First Adult Recreational Cannabis Collections™ Variety Kit

    MONCTON, NB, Sept. 12, 2018 /CNW/ - Organigram Holdings Inc. (TSX VENTURE:OGI) (OTCQX:OGRMF - News), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of medical marijuana, today announced that it has chosen to include its award-winning sativa flower, Wabanaki, in the AHLOT Cannabis Collections: Discovery Series Vol. 1™. The variety pack has been selected for distribution by the Ontario Cannabis Store and will be available to consumers following the launch of the adult recreational market on Oct. 17. "We are thrilled to have an award-winning Organigram flower included in this offering," says AHLOT Chief Executive Officer, Greg Pantelic.

  • ACCESSWIRE10 days ago

    Today's Research Reports on Aralez Pharmaceuticals, OrganiGram Holdings, Oncolytics Biotech and Aptose Biosciences

    NEW YORK, NY / ACCESSWIRE / September 10, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register ...

  • CNW Group14 days ago

    Organigram Announces Trading on the OTCQX® Best Market

    MONCTON, NB, Sept. 6, 2018 /CNW/ - Organigram Holdings Inc. (TSX VENTURE:OGI) (OTCQX:OGRMF - News), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of medical marijuana, today announced that it has qualified to trade on the OTCQX® Best Market. Organigram has seen its U.S. trading volumes as a percentage of its overall trading volumes increase substantially in 2018 and believes that upgrading to the OTCQX® Best Market should help drive increased cross-border liquidity.

  • CNW Group15 days ago

    Supreme Cannabis Approved for Additional Production Capacity

    Supreme Cannabis receives approval for additional 20,000 sq.ft. of flowering rooms at 7ACRES facility New flowering rooms expected to support an increase in annual production potential to 13,330kg TORONTO ...

  • CNW Group20 days ago

    Organigram Announces the Issuance of RSU Awards

    MONCTON, NB, Aug. 31, 2018 /CNW/ - Organigram Holdings Inc. (TSX VENTURE:OGI) (OTCQB:OGRMF - News), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of medical marijuana, today announced the grant of restricted share units ("RSUs") to certain officers, directors and employees of the Company. Pursuant to the terms of the Equity Incentive Plan (the "Plan") of the Company as approved by shareholders at the Annual and Special Meeting of the Shareholders held December 19, 2017, 145,201 RSUs were today awarded to officers, directors and employees pursuant to the Company's Plan. The issuance of the RSUs are subject to all required approvals, including, if applicable, the approval to the TSX Venture Exchange.

  • CNW Group23 days ago

    Supreme Cannabis Secures Supply Agreements with Nova Scotia and Prince Edward Island

    The Company now has six provincial supply agreements and is listed in provinces from coast-to-coast. Supreme is now one of only six cannabis companies with five or more provincial supply agreements. Supreme ...

  • CNW Group24 days ago

    Canadian parents concerned about legalization of cannabis, agree not enough information available to youth about cannabis use risks

    MONCTON, NB, Aug. 27, 2018 /CNW/ - According to a survey commissioned by Organigram Inc., a leading licensed producer of medical marijuana (Parent company: Organigram Holdings Inc. (TSXV:OGI.V - News) (OTCQB:OGRMF - News)), a majority of Canadian parents (60 per cent) are concerned about cannabis legalization. More than half of the parents surveyed (54 per cent) feel there is currently not enough information available to youth about the risks associated with cannabis use and only three in ten parents feel "very prepared" to educate their children about cannabis. "As we move toward the legalization of cannabis, it's important that we take pulse checks along the way," said Ray Gracewood, Chief Commercial Officer, Organigram.

  • CNW Group27 days ago

    Organigram signs supply agreement with Nova Scotia Liquor Corporation

    Agreement is Company's sixth provincial supply arrangement,  continues to build Company's national presence MONCTON, NB , Aug. 24, 2018 /CNW/ - Organigram Holdings Inc. (TSXV: OGI) (OTCQB: OGRMF), the ...

  • Baystreetlast month

    Stocks in play: Organigram Holdings Inc.

    Has been approved as a supplier of cannabis for the province of Ontario.Under the terms of the agreement ...

  • CNW Grouplast month

    Organigram becomes an official cannabis supplier to the Province of Ontario, Canada's largest adult recreational market

    MONCTON, NB, Aug. 21, 2018 /CNW/ - Organigram Holdings Inc. (TSX VENTURE:OGI) (OTCQB:OGRMF - News), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of medical marijuana, is pleased to announce that it has been approved as a supplier of cannabis for the province of Ontario. Under the terms of the agreement with Ontario Cannabis Retail Corporation (OCRC), Organigram will provide the Province with 27 SKUs of products including dried flower, pre-rolled product, cannabis oils and the premium offering of the Edison Reserve brand.

  • Here Are the Top 10 Marijuana Stocks
    The Motley Foollast month

    Here Are the Top 10 Marijuana Stocks

    Most investors will be familiar with Canopy Growth Corp (TSX:WEED)(NYSE:CGC), but there are many other intriguing top players.

  • ACCESSWIRElast month

    Today's Research Reports on Emblem, OrganiGram Holdings, Oncolytics Biotech and Aptose Biosciences

    NEW YORK, NY / ACCESSWIRE / August 10, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register ...

  • CNW Group2 months ago

    Mount Allison receives support from Organigram Inc. and NB Regional Development Corporation to support cannabis harms reduction education programming and initiatives

    MONCTON, NB, Aug. 1, 2018 /CNW/ - Organigram Holdings Inc. (TSX VENTURE:OGI) (OTCQB:OGRMF - News), the parent company of Organigram Inc., a leading  licensed producer of medical marijuana and the New Brunswick Regional Development Corporation (RDC) will provide funding to Mount Allison to support the University's efforts to ensure the new legislation is fully communicated on campus, and to implement appropriate harms reduction initiatives established by the University. In preparation for the legalization of cannabis on October 17, the University developed a working group earlier this year made up of students (including representatives from the Mount Allison Students Union), and staff.

  • CNW Group2 months ago

    Organigram Announces Record Q3 Financial Results - Net Income of $2.8 Million for the Quarter

    Growth in production, dried flower sales, oil sales, inventory and the announcement of numerous sales agreements positions Organigram for successful launch of adult recreational use market MONCTON, NB ...

  • Baystreet2 months ago

    Big Investors Backing A Global Marijuana Boom In 2018

    Imagine being able to take a few million dollars in start-up capital and turn it into $193 million ...

  • ACCESSWIRE2 months ago

    Canadian Exchanges Stock Scanner IMV Inc, IntelliPharmaCeutics International, OrganiGram Holdings, and Antibe Therapeutics

    LONDON, UK / ACCESSWIRE / July 25, 2018 / Active-Investors free stock reports for this morning include these Toronto Exchanges' equitiesfrom the Biotechnology industry: IMV Inc., IntelliPharmaCeutics International, OrganiGram Holdings, and Antibe Therapeutics. The TSX Venture Exchange shaved off 3.89 points, or 0.55%, to finish at 706.42. Today's stocks of interest consist of: IMV Inc. (TSX: IMV), IntelliPharmaCeutics International Inc. (TSX: IPCI), OrganiGram Holdings Inc. (TSX-V: OGI), and Antibe Therapeutics Inc. (TSX-V: ATE).

  • Baystreet2 months ago

    Stocks in play: Organigram Inc.

    Announced one of its branches is in the final stages of planting the remaining three of the 16 three-tier ...

  • CNW Group2 months ago

    Organigram Provides Expansion Update as Phase 4 Construction Begins

    MONCTON, NB, July 23, 2018 /CNW/ - Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQB:OGRMF - News), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of medical marijuana based in Moncton, New Brunswick, is in the final stages of planting the remaining three of the sixteen three-tier Phase 3 cultivation rooms which have been licensed by Health Canada. In total, the Company's Phase 3 expansion has increased Organigram's target dried flower equivalent production capacity from an estimated 22,000 kg/annum (Phases 1 and 2) to 36,000 kg/annum (Phases 1, 2 and 3).

  • ACCESSWIRE2 months ago

    Today's Research Reports on Emblem, OrganiGram, Oncolytics Biotech and Aptose Biosciences

    NEW YORK, NY / ACCESSWIRE / July 11, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register ...

  • CNW Group2 months ago

    Organigram Signs Strategic Supplier Agreement with Hiku Brands

    Agreement brings up to 1,000kg of Organigram's premium indoor-grown cannabis products to Tokyo Smoke, Hiku's licensed chain of cannabis stores in Manitoba MONCTON, NB , July 10, 2018 /CNW/ - Organigram ...